357 related articles for article (PubMed ID: 26362194)
1. Novel BRAF and KRAS Mutations in Papillary Thyroid Carcinoma Arising in Struma Ovarii.
Tan A; Stewart CJ; Garrett KL; Rye M; Cohen PA
Endocr Pathol; 2015 Dec; 26(4):296-301. PubMed ID: 26362194
[TBL] [Abstract][Full Text] [Related]
2. Follicular variant papillary thyroid carcinoma arising in struma ovarii.
Boutross-Tadross O; Saleh R; Asa SL
Endocr Pathol; 2007; 18(3):182-6. PubMed ID: 18058267
[TBL] [Abstract][Full Text] [Related]
3. BRAF in papillary thyroid carcinoma of ovary (struma ovarii).
Schmidt J; Derr V; Heinrich MC; Crum CP; Fletcher JA; Corless CL; Nosé V
Am J Surg Pathol; 2007 Sep; 31(9):1337-43. PubMed ID: 17721188
[TBL] [Abstract][Full Text] [Related]
4. RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii.
Coyne C; Nikiforov YE
Endocr Pathol; 2010 Jun; 21(2):144-7. PubMed ID: 19898969
[TBL] [Abstract][Full Text] [Related]
5. BRAF T1799A mutation occurring in a case of malignant struma ovarii.
Flavin R; Smyth P; Crotty P; Finn S; Cahill S; Denning K; Jinghuan Li ; O'Regan E; O'Leary J; Sheils O
Int J Surg Pathol; 2007 Apr; 15(2):116-20. PubMed ID: 17478764
[TBL] [Abstract][Full Text] [Related]
6. Role of gene sequencing in classifying struma ovarii: BRAF p.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
Neyrand S; Trecourt A; Lopez J; Just PA; Descotes F; Borson-Chazot F; Ray-Coquard I; Decaussin-Petrucci M; Devouassoux-Shisheboran M
Histopathology; 2024 Jan; 84(2):291-300. PubMed ID: 37771077
[TBL] [Abstract][Full Text] [Related]
7. Unilateral follicular variant of papillary thyroid carcinoma with unique KRAS mutation in struma ovarii in bilateral ovarian teratoma: a rare case report.
Stanojevic B; Dzodic R; Saenko V; Milovanovic Z; Krstevski V; Radlovic P; Buta M; Rulic B; Todorovic L; Dimitrijevic B; Yamashita S
BMC Cancer; 2012 Jun; 12():224. PubMed ID: 22682753
[TBL] [Abstract][Full Text] [Related]
8. Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutations.
Poli R; Scatolini M; Grosso E; Maletta F; Gallo M; Liscia D; Nelva A; Cesario F; Forte G; Metovic J; Volante M; Arvat E; Papotti M
Endocrine; 2021 Jan; 71(1):216-224. PubMed ID: 32743766
[TBL] [Abstract][Full Text] [Related]
9. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.
Roth LM; Miller AW; Talerman A
Int J Gynecol Pathol; 2008 Oct; 27(4):496-506. PubMed ID: 18753973
[TBL] [Abstract][Full Text] [Related]
10. Pathology of Struma Ovarii: A Report of 96 Cases.
Wei S; Baloch ZW; LiVolsi VA
Endocr Pathol; 2015 Dec; 26(4):342-8. PubMed ID: 26374222
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of malignant struma ovarii and cervical papillary thyroid carcinoma.
Leong A; Roche PJ; Paliouras M; Rochon L; Trifiro M; Tamilia M
J Clin Endocrinol Metab; 2013 Dec; 98(12):4599-605. PubMed ID: 24217901
[TBL] [Abstract][Full Text] [Related]
12. Editorial on: Role of gene sequencing in classifying struma ovarii: BRAF P.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
McCluggage WG
Histopathology; 2024 Jan; 84(2):288-290. PubMed ID: 38110823
[No Abstract] [Full Text] [Related]
13. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases.
Devaney K; Snyder R; Norris HJ; Tavassoli FA
Int J Gynecol Pathol; 1993 Oct; 12(4):333-43. PubMed ID: 8253550
[TBL] [Abstract][Full Text] [Related]
14. Struma Ovarii With Malignant Transformation and Germline KIT Mutation: A Case Report With Review of the Literature.
Ma D; Guseva NV; Dahmoush L; Robinson RA
Int J Gynecol Pathol; 2016 Sep; 35(5):442-7. PubMed ID: 27258816
[TBL] [Abstract][Full Text] [Related]
15. Papillary thyroid cancer in a struma ovarii: a report of a rare case.
Monti E; Mortara L; Zupo S; Dono M; Minuto F; Truini M; Naseri M; Giusti M
Hormones (Athens); 2015; 14(1):154-9. PubMed ID: 25402391
[TBL] [Abstract][Full Text] [Related]
16. It Does Exist! Diagnosis and Management of Thyroid Carcinomas Originating in Struma Ovarii.
Smith LP; Brubaker LW; Wolsky RJ
Surg Pathol Clin; 2023 Mar; 16(1):75-86. PubMed ID: 36739168
[TBL] [Abstract][Full Text] [Related]
17. Synchronous thyroid cancer and malignant struma ovarii: concordant mutations and microRNA profile, discordant loss of heterozygosity loci.
Seo GT; Minkowitz J; Kapustin DA; Fan J; Minkowitz G; Minkowitz M; Dowling E; Matloob A; Asti D; Dhar M; Shutty C; Brickman A; Urken ML; Brandwein-Weber M; Finkelstein SD
Diagn Pathol; 2023 Apr; 18(1):47. PubMed ID: 37072862
[TBL] [Abstract][Full Text] [Related]
18. BRAF and RAS Mutational Status in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Invasive Subtype of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma in Korea.
Kim M; Jeon MJ; Oh HS; Park S; Kim TY; Shong YK; Kim WB; Kim K; Kim WG; Song DE
Thyroid; 2018 Apr; 28(4):504-510. PubMed ID: 29439609
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature.
Anastasilakis AD; Ruggeri RM; Polyzos SA; Makras P; Molyva D; Campennì A; Gkiomisi A; Balaris C; Fotiadis PP; Tuccari G; Papachatzopoulos S
Metabolism; 2013 Oct; 62(10):1350-6. PubMed ID: 23806737
[TBL] [Abstract][Full Text] [Related]
20. Malignant struma ovarii with thyroid-type papillary and poorly differentiated carcinoma: a case report.
Terayama N; Fujiwara S; Ueda S; Yamada T; Ohmichi M
J Med Case Rep; 2022 Sep; 16(1):348. PubMed ID: 36176008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
